The Developmental Therapeutics Core (DTC), under the umbrella of the Center of the Developmental Therapeutics (CDT), provides services focused on supporting the translation of new therapeutics to the clinic. The Core supports investigators interested in advancing new compounds into clinical trials including drug assessment and clinical protocol support. In addition, the DTC will interact with universities and companies in the community that are interested in utilizing DTC expertise to help advance their translational projects.
The growing recognition of the complexity of flow cytometric analysis has made the Flow Cytometry Core an important research resource and service provider, as well as a prudent investment for academic institutions. The facility strives to meet its scientific and technical mission through quality services in a cost-effective and timely manner. Serving more than 175 investigators at Northwestern, the facility balances productivity with quality to minimize the cost per research project, keep overall costs contained, and provide the necessary scientific support.
The mission of Northwestern Proteomics is to develop new proteomics technologies, to apply them to timely questions in basic, translational and clinical research, and to educate researchers throughout the Chicagoland area and communicate its research findings to the scientific community at large.
The NUSeq Core is a shared resource facility that serves investigators at Northwestern University, affiliated institutions, and external academic and commercial organizations. We bring services previously provided by the Genomics Core Facility and Next Generation Sequencing Core together into one consolidated operation.
The facility provides a wide range of sequencing, genotyping, and gene expression profiling options to meet your needs, in addition to other genomic services such as DNA extraction, RNA quality control, and whole genome amplification.